These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33424978)

  • 1. CD133 Antigen as a Potential Marker of Melanoma Stem Cells:
    Kloskowski T; Jarząbkowska J; Jundziłł A; Balcerczyk D; Buhl M; Szeliski K; Bodnar M; Marszałek A; Drewa G; Drewa T; Pokrywczyńska M
    Stem Cells Int; 2020; 2020():8810476. PubMed ID: 33424978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-92 Expression in CD133
    Shidal C; Singh NP; Nagarkatti P; Nagarkatti M
    Cancer Res; 2019 Jul; 79(14):3622-3635. PubMed ID: 31015227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
    Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
    Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
    Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
    de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
    APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line.
    Rajabi Fomeshi M; Ebrahimi M; Mowla SJ; Firouzi J; Khosravani P
    Cell J; 2016; 18(1):21-7. PubMed ID: 27054115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
    Grasso C; Anaka M; Hofmann O; Sompallae R; Broadley K; Hide W; Berridge MV; Cebon J; Behren A; McConnell MJ
    BMC Cancer; 2016 Sep; 16(1):726. PubMed ID: 27613604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a subpopulation of CD133
    Gao J; Yang T; Wang X; Zhang Y; Wang J; Zhang B; Tang D; Liu Y; Gao T; Lin Q; Tang J; Cai J
    Cancer Cell Int; 2021 Mar; 21(1):157. PubMed ID: 33685462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
    Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
    Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
    Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
    Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
    Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
    Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma.
    Rappa G; Fodstad O; Lorico A
    Stem Cells; 2008 Dec; 26(12):3008-17. PubMed ID: 18802032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
    PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis.
    Madjd Z; Erfani E; Gheytanchi E; Moradi-Lakeh M; Shariftabrizi A; Asadi-Lari M
    Int J Biol Markers; 2016 May; 31(2):e118-25. PubMed ID: 27102864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.